Clinical Trial Update: A Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With Capecitabine in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports on the safety, tolerability and pharmacokinetics of TAS-114 in combination with capecitabine in patients with advanced solid t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Capecitabine (Xeloda) (Capecitabine)
• TAS-114

Snippet

Sponsor: Taiho Oncology, Inc. | Conditions: Neoplasms | Phase 1 | Status: COMPLETED